Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Research graph
References from A Major Role of <scp>VEGFR1</scp> Blockade in Protecting Glomerular Endothelium in Experimental Diabetes. Local targets link to admitted publications; unresolved targets remain external evidence.
10.1016/s0140‐6736(23)01301‐6
10.1016/s0140‐6736(23)01301‐6 · External reference
10.1186/s12933‐023‐02056‐3
10.1186/s12933‐023‐02056‐3 · External reference
10.1056/nejmcp011773
10.1056/nejmcp011773 · External reference
Incidence Rates and Predictors of Microvascular and Macrovascular Complications in Patients With Type 2 Diabetes: Results From the Longitudinal Global Discover Study
10.1016/j.ahj.2021.10.181 · 2022 · External reference
10.1038/nrneph.2018.9
10.1038/nrneph.2018.9 · External reference
10.1097/hjh.0000000000001674
10.1097/hjh.0000000000001674 · External reference
10.1038/ki.2012.234
10.1038/ki.2012.234 · External reference
10.1016/j.kint.2019.04.024
10.1016/j.kint.2019.04.024 · External reference
10.1002/path.5862
10.1002/path.5862 · External reference
10.1681/asn.2021030294
10.1681/asn.2021030294 · External reference
10.1016/j.biopha.2021.111918
10.1016/j.biopha.2021.111918 · External reference
10.1056/nejmoa042167
10.1056/nejmoa042167 · External reference
10.1681/asn.2005121324
10.1681/asn.2005121324 · External reference
10.1038/nrneph.2010.58
10.1038/nrneph.2010.58 · External reference
The Biology of VEGF and Its Receptors
10.1038/nm0603-669 · 2003 · External reference
10.1038/s41392‐025‐02249‐0
10.1038/s41392‐025‐02249‐0 · External reference
10.1084/jem.20210565
10.1084/jem.20210565 · External reference
10.1146/annurev‐physiol‐021115‐105412
10.1146/annurev‐physiol‐021115‐105412 · External reference
10.1111/j.1523‐1755.2004.00621.x
10.1111/j.1523‐1755.2004.00621.x · External reference
10.1172/jci200317423
10.1172/jci200317423 · External reference
10.3389/fphar.2021.788886
10.3389/fphar.2021.788886 · External reference
10.1161/hypertensionaha.122.19427
10.1161/hypertensionaha.122.19427 · External reference
10.1016/j.jash.2018.03.008
10.1016/j.jash.2018.03.008 · External reference
VEGF Inhibition and Renal Thrombotic Microangiopathy
10.1056/nejmoa0707330 · 2008 · External reference
10.2337/diabetes.48.11.2229
10.2337/diabetes.48.11.2229 · External reference
10.1111/j.1523‐1755.2005.00067.x
10.1111/j.1523‐1755.2005.00067.x · External reference
10.1681/asn.2009121290
10.1681/asn.2009121290 · External reference
10.1038/nm731
10.1038/nm731 · External reference
10.1007/s00424‐016‐1843‐4
10.1007/s00424‐016‐1843‐4 · External reference
10.2353/ajpath.2006.050398
10.2353/ajpath.2006.050398 · External reference
10.1186/s13054‐017‐1841‐8
10.1186/s13054‐017‐1841‐8 · External reference
10.3390/ijms242216543
10.3390/ijms242216543 · External reference
10.1159/000442679
10.1159/000442679 · External reference
The Glomerular Endothelium Emerges as a Key Player in Diabetic Nephropathy
10.1038/ki.2012.258 · 2012 · External reference
10.1038/s41598‐018‐23244‐2
10.1038/s41598‐018‐23244‐2 · External reference
10.1091/mbc.e03‐08‐0593
10.1091/mbc.e03‐08‐0593 · External reference
10.1681/asn.2007101138
10.1681/asn.2007101138 · External reference
Placenta Growth Factor. Potentiation of Vascular Endothelial Growth Factor Bioactivity, In Vitro and In Vivo, and High Affinity Binding to Flt‐1 but Not to Flk‐1/KDR
10.1016/s0021-9258(18)47298-5 · 1994 · External reference
10.1681/asn.2010030295
10.1681/asn.2010030295 · External reference
10.1097/00041552‐200401000‐00002
10.1097/00041552‐200401000‐00002 · External reference
10.1038/s41467‐023‐43847‐2
10.1038/s41467‐023‐43847‐2 · External reference
10.3390/jcm9020302
10.3390/jcm9020302 · External reference
10.1681/asn.2014040350
10.1681/asn.2014040350 · External reference
10.1038/ki.2010.64
10.1038/ki.2010.64 · External reference
10.1016/j.cell.2012.08.037
10.1016/j.cell.2012.08.037 · External reference
10.2337/db11‐1655
10.2337/db11‐1655 · External reference
10.1007/s00424‐007‐0212‐8
10.1007/s00424‐007‐0212‐8 · External reference
10.1016/j.ajpath.2019.07.021
10.1016/j.ajpath.2019.07.021 · External reference
10.1002/path.3964
10.1002/path.3964 · External reference
10.1172/jci.insight.154164
10.1172/jci.insight.154164 · External reference
10.3390/ijms24065380
10.3390/ijms24065380 · External reference
10.1016/j.kint.2026.03.016
10.1016/j.kint.2026.03.016 · External reference
SU5416 Is a Potent and Selective Inhibitor of the Vascular Endothelial Growth Factor Receptor (Flk‐1/KDR) That Inhibits Tyrosine Kinase Catalysis, Tumor Vascularization, and Growth of Multiple Tumor Types
1999 · External reference